-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Lyell Immunopharma, Inc. quarterly/annual Revenues history and growth rate from 2019 to Q3 2025.
- Lyell Immunopharma, Inc. Revenues for the quarter ending September 30, 2025 was $15K, a 55.9% decline year-over-year.
- Lyell Immunopharma, Inc. Revenues for the twelve months ending September 30, 2025 was $41K, a 34.9% decline year-over-year.
- Lyell Immunopharma, Inc. annual Revenues for 2024 was $61K, a 53.1% decline from 2023.
- Lyell Immunopharma, Inc. annual Revenues for 2023 was $130K.
- Lyell Immunopharma, Inc. annual Revenues for 2022 was $84.7M.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Revenues, Annual (USD)
Revenues, YoY Annual Growth (%)